STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ICCC IMMUCELL CORPORATION StockScouter® Report
7
StockScouter® Score
IMMUCELL CORPORATION, a micro cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Short-term relative price momentum exhibits moderate strength. Postive/Neutral
- Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like ICCC
Concerns
- The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
D
C
D
C